Butyltolylquinuclidine

Butyltolylquinuclidine
Systematic (IUPAC) name
(2R,3S,4S)-2-butyl-3-p-tolylquinuclidine
Clinical data
Pregnancy cat.  ?
Legal status Legal
Identifiers
ATC code  ?
PubChem CID 9903250
Chemical data
Formula C18H27N 
Mol. mass 257.414 g/mol
SMILES eMolecules & PubChem
 Y(what is this?)  (verify)

2-Butyl-3-(p-tolyl)quinuclidine (BTQ) is a stimulant DRI.[1] It is one of a number of substituted quinuclidine derivatives developed as potential medications for the treatment of cocaine abuse,[2] and produces similar effects to cocaine in animal studies, although milder and longer lasting.

References

  1. ^ Sakamuri, S.; Enyedy, I. J.; Zaman, W. A.; Tella, S. R.; Kozikowski, A. P.; Flippen-Anderson, J. L.; Farkas, T.; Johnson, K. M. et al. (2003). "2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitors". Bioorganic & medicinal chemistry 11 (6): 1123–1136. doi:10.1016/S0968-0896(02)00450-9. PMID 12614900.  edit
  2. ^ Enyedy, I. J.; Sakamuri, S.; Zaman, W. A.; Johnson, K. M.; Wang, S. (2003). "Pharmacophore-based discovery of substituted pyridines as novel dopamine transporter inhibitors". Bioorganic & medicinal chemistry letters 13 (3): 513–517. doi:10.1016/S0960-894X(02)00943-5. PMID 12565962.  edit